Vanguard Group Inc Enochian Biosciences Inc Transaction History

Vanguard Group Inc

$5.12 Trillion
Q2 2024

A detailed history of Vanguard Group Inc transactions in Enochian Biosciences Inc stock. As of the latest transaction made, Vanguard Group Inc holds 5,644,027 shares of ENOB stock, worth $26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,644,027

Previous 3,916,672 44.1%

Holding current value

$26 Million

Previous $18 Million 44.11%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	N/A	1,727,355 Added 44.1%	5,644,027 $26 Million
Q1 2024 May 10, 2024	BUY	N/A	3,526,565 Added 904.0%	3,916,672 $18 Million
Q4 2023 Feb 14, 2024	BUY	$4.3 - $4.7 $510,762 - $558,275	118,782 Added 43.78%	390,107 $1.79 Million
Q3 2023 Nov 14, 2023	BUY	$0.0 - $4.46 $0 - $197,560	44,296 Added 19.51%	271,325 $1.21 Million
Q2 2023 Aug 14, 2023	SELL	$0.4 - $1.3 $38,098 - $123,821	-95,247 Reduced 29.55%	227,029 $129,000
Q1 2023 May 15, 2023	SELL	$0.91 - $1.31 $397,148 - $571,719	-436,427 Reduced 57.52%	322,276 $296,000
Q4 2022 Feb 10, 2023	BUY	$1.03 - $2.13 $3,646 - $7,540	3,540 Added 0.47%	758,703 $781,000
Q3 2022 Nov 14, 2022	BUY	$1.7 - $2.86 $29,794 - $50,124	17,526 Added 2.38%	755,163 $1.37 Million
Q2 2022 Aug 12, 2022	SELL	$1.93 - $8.73 $383,369 - $1.73 Million	-198,637 Reduced 21.22%	737,637 $1.42 Million
Q1 2022 May 13, 2022	SELL	$4.42 - $9.0 $9,264 - $18,864	-2,096 Reduced 0.22%	936,274 $7.73 Million
Q4 2021 Feb 14, 2022	BUY	$6.71 - $12.55 $4.57 Million - $8.55 Million	681,314 Added 265.04%	938,370 $6.84 Million
Q3 2021 Nov 12, 2021	SELL	$4.56 - $7.88 $75,696 - $130,808	-16,600 Reduced 6.07%	257,056 $1.73 Million
Q2 2021 Aug 13, 2021	BUY	$2.94 - $6.79 $804,548 - $1.86 Million	273,656 New	273,656 $1.36 Million

Others Institutions Holding ENOB

# of Institutions

Shares Held

14M

Call Options Held

33.7K

Put Options Held

View Full List

About Enochian Biosciences Inc

Ticker ENOB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,950,000
Market Cap $244M
Description
Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...

More about ENOB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Enochian Biosciences Inc Transaction History